The size of the osteoporosis drugs market will power at a compound annual growth rate of 5.2% during 2022-2030, to touch a value of USD 22,947 million by 2030. This growth of the industry is due to increasing healthcare expenditure, the high prevalence of osteoporosis and the speedy urbanization affecting bone health. India is one of the fastest growing markets … Continua a leggere→